11 reports of this reaction
1.6% of all BENZOCAINE AND MENTHOL reports
#13 most reported adverse reaction
URINARY TRACT INFECTION is the #13 most commonly reported adverse reaction for BENZOCAINE AND MENTHOL, manufactured by RB Health (US) LLC. There are 11 FDA adverse event reports linking BENZOCAINE AND MENTHOL to URINARY TRACT INFECTION. This represents approximately 1.6% of all 672 adverse event reports for this drug.
Patients taking BENZOCAINE AND MENTHOL who experience urinary tract infection should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
URINARY TRACT INFECTION is a less commonly reported adverse event for BENZOCAINE AND MENTHOL, but still significant enough to appear in the safety profile.
In addition to urinary tract infection, the following adverse reactions have been reported for BENZOCAINE AND MENTHOL:
The following drugs have also been linked to urinary tract infection in FDA adverse event reports:
URINARY TRACT INFECTION has been reported as an adverse event in 11 FDA reports for BENZOCAINE AND MENTHOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
URINARY TRACT INFECTION accounts for approximately 1.6% of all adverse event reports for BENZOCAINE AND MENTHOL, making it a notable side effect.
If you experience urinary tract infection while taking BENZOCAINE AND MENTHOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.